Clinical Trial Update: Study to Assess the Safety and Efficacy of DERMASEAL for the Treatment of Split-Thickness Skin Graft Donor Site Wounds [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and efficacy of DERMASEAL for treating split-thickness skin graft donor site wounds is currently not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Graft Complications

Drugs mentioned

• DERMASEAL

Snippet

Sponsor: Hobart W. Harris | Conditions: Skin Graft Complications | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING